Združene države Amerike - angleščina - NLM (National Library of Medicine)

watson labs - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - tablet - 100 mg - for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms: escherichia coli, proteus mirabilis, klebsiella pneumoniae, enterobacter species and coagulase-negative staphylococcus species, including s. saprophyticus. cultures and susceptibility tests should be performed to determine the susceptibility of the bacteria to trimethoprim. therapy may be initiated prior to obtaining the results of these tests. trimethoprim tablets are contraindicated in individuals hypersensitive to trimethoprim and in those with documented megaloblastic anemia due to folate deficiency.

Združene države Amerike - angleščina - NLM (National Library of Medicine)

carilion materials management - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - trimethoprim 100 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of trimethoprim tablets, usp and other antibacterial drugs, trimethoprim tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms: escherichia coli , proteus mirabilis , klebsiella pneumoniae , enterobacter species, and coagulase-negative staphylococcus species, including s. saprophyticus . cultures and susceptibility tests should be performed to determine the susceptibility of the bacteria to trimethoprim. therapy may be initiated prior to obtaining the

Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

crescent pharma ltd - trimethoprim - oral tablet - 100mg

Malta - angleščina - Medicines Authority

wockhardt uk limited ash road north, wrexham, ll13 9uf, united kingdom - sulfadiazine - tablet - sulfadiazine 500 mg - antibacterials for systemic use

Velika Britanija - angleščina - myHealthbox

milpharm limited - trimethoprim - tablets - 200mg - systemic antibacterial - treatment of susceptible infections caused by trimethoprim sensitive organisms including most gram-positive and gram-negative aerobic organisms, including haemophilus influenzae, streptococcus pneumoniae, klebsiella pneumonia, staphylococcus aureus, eschersichia coli, enterobacter, proteus and streptococcus faecalis. exceptions include anaerobic bacteria. mycobacterium tuberculosis, neisseria gonorrhoeae, pseudomonas aeruginosa and treponema pallidum. prophylaxis of recurrent urinary tract infections. consideration should be given to official guidance on the appropriate use of antibacterial agents

Velika Britanija - angleščina - myHealthbox

milpharm limited - trimethoprim - tablets - 100mg - treatment of susceptible infections caused by trimethoprim sensitive organisms including most gram-positive and gram-negative aerobic organisms, including haemophilus influenzae, streptococcus pneumoniae, klebsiella pneumonia, staphylococcus aureus, eschersichia coli, enterobacter, proteus and streptococcus faecalis. exceptions include anaerobic bacteria. mycobacterium tuberculosis, neisseria gonorrhoeae, pseudomonas aeruginosa and treponema pallidum. prophylaxis of recurrent urinary tract infections. consideration should be given to official guidance on the appropriate use of antibacterial agents

Združene države Amerike - angleščina - NLM (National Library of Medicine)

macleod pharmaceuticals inc. - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - trimethoprim 67 mg in 1 g

Združene države Amerike - angleščina - NLM (National Library of Medicine)

macleod pharmaceuticals inc. - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - trimethoprim 67 mg in 1 g

Avstralija - angleščina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - trimethoprim; sulfadiazine - parenteral liquid/solution/suspension - trimethoprim pyrimidine active 80.0 mg/ml; sulfadiazine sulfanyl active 400.0 mg/ml - antibiotic & related - cattle | horse | pigs | sheep ewe - dry | beef | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | co - bacterial infection | infections of the alimentary tract | infections of the respiratory tract | infections of the urogenital tract | acute respiratory infections | amoxycillin sensitive bacteria | associated with viral disease | bronchiseptica | bronchitis | cystitis | gram negative organisms | gram positive organisms | metritis | nephritis | pharyngitis | pneumonia | post parturient bacterial infe | primary bacterial infection | sulfadiazine sensitive bacteri | tonsillitis | trimethoprim sensitive bacteri | tylosin sensitive bacteria

Avstralija - angleščina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - trimethoprim; sulfadiazine - oral bolus + intra vaginal/uterine - trimethoprim pyrimidine active 200.0 mg/pb; sulfadiazine sulfanyl active 1000.0 mg/pb - antibiotic & related - cattle | horse | pigs | sheep | beef | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | colt | cow | - bacterial infection | amoxycillin sensitive bacteria | associated with viral disease | gram negative organisms | gram positive organisms | post parturient bacterial infe | primary bacterial infection | sulfadiazine sensitive bacteri | trimethoprim sensitive bacteri | tylosin sensitive bacteria